Back to Pharmaceutical Members (PH)
Bioscience Company Member
Organization Overview
Synap Biotech is reimagining neurological recovery through intranasal nanobody therapy that unlocks the brain’s natural ability to repair itself.
Our lead program targets Nogo-A, a key inhibitor of neuroplasticity, to promote regeneration after stroke, traumatic brain injury, and other neurological disorders.
By combining nanobody precision with non-invasive intranasal delivery, we aim to restore function, reduce disability, and help millions of patients regain independence.
Our lead program targets Nogo-A, a key inhibitor of neuroplasticity, to promote regeneration after stroke, traumatic brain injury, and other neurological disorders.
By combining nanobody precision with non-invasive intranasal delivery, we aim to restore function, reduce disability, and help millions of patients regain independence.
Bioscience Company Member